GRDN
Guardian Pharmacy Services, Inc.
NYSE · Healthcare · Medical - Distribution · US
$44.99
−0.13%Next report
Analyst consensus
- Next report date
- Nov 9, 2026
- EPS estimate
- $0.32
- Revenue estimate
- $365.8M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- $0.29
- EPS estimate
- $0.26
- Revenue actual
- $351.8M
- Revenue estimate
- $340.4M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +21.1%
- Revenue beats (12Q)
- 4
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | $0.26 | $0.29 | Beat 10.81% | $351.8M |
| May 6, 2026 | $0.24 | $0.29 | Beat 20.83% | $336.6M |
| Mar 11, 2026 | $0.27 | $0.37 | Beat 38.32% | $397.6M |
| Mar 26, 2025 | $0.21 | $0.24 | Beat 14.29% | $338.6M |
| Sep 26, 2024 | — | $0.17 | — | $300.0M |
| Dec 31, 2023 | — | $0.10 | — | $1.0B |
| Sep 30, 2023 | — | -$0.19 | — | $262.7M |
| Jun 30, 2023 | — | $0.35 | — | $253.4M |
| Jun 30, 2022 | — | -$0.10 | — | $224.1M |
| Mar 31, 2022 | — | $0.30 | — | $211.0M |
| Dec 31, 2021 | — | $0.07 | — | $792.1M |
| Sep 30, 2021 | — | $0.20 | — | $203.6M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 9, 2026